BIO-KEY International convened its Annual Meeting on September 3, 2026, but adjourned it because stockholders failed to approve Proposal 4, which sought authorization to issue up to 1,236,668 shares of common stock upon exercise of warrants from an August 10, 2026 inducement transaction. The meeting is reconvened for October 2, 2026, at the company's Holmdel, New Jersey offices, with no changes to the proposals or polls. BIO-KEY International operates in the biometric security industry, providing fingerprint and facial recognition authentication solutions.
